In breast cancer, the over-expression of SDF1 protein was associated with positive estrogen receptor (ER) status, the breast cancer subtype previously associated with the presence of BOLCs and the development of bone metastases [28,32]. This evidence concerns the gene CXCL12 and breast carcinoma.